To tackle risks posed by pharmaceutical pollution, source, use, and end-of-pipe measures are needed. Source-oriented, e.g. green design require transformation(s) by many pharmaceutical actors and interdisciplinary effort to support new approaches. Today, there is little interdisciplinary interaction and few empirical studies on how actors implement green transformation in practice. This project examines the cross-cutting effects of EU chemicals policy and legislation – supporting green transformations – on the practices of pharmaceutical actors and how they perceive the depth of green transformations needed. The research, performed at the UEF, involves scholars in law, pharmacy, and environmental science. Theoretical literature is linked to empirical evidence from the analysis of policy and legal documents and qualitative interviews with different stakeholders. The outcomes inform EU and national chemicals and pharmaceutical policies and support deep green transformations in practice.

2023

2027